ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 76 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $451,000 | +2.3% | 210,000 | +50.0% | 0.17% | +5.0% |
Q1 2017 | $441,000 | -29.3% | 140,000 | -41.7% | 0.16% | -29.1% |
Q4 2016 | $624,000 | -19.8% | 240,000 | +20.0% | 0.23% | -22.0% |
Q3 2016 | $778,000 | +122.9% | 200,000 | +53.8% | 0.29% | +117.2% |
Q2 2016 | $349,000 | +642.6% | 130,000 | +738.7% | 0.13% | +605.3% |
Q1 2016 | $47,000 | -46.0% | 15,500 | -3.1% | 0.02% | -38.7% |
Q3 2014 | $87,000 | – | 16,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 6,574,060 | $25,376,000 | 1.97% |
SENZAR ASSET MANAGEMENT, LLC | 1,040,681 | $4,017,000 | 0.98% |
Cormorant Asset Management, LP | 850,000 | $3,281,000 | 0.51% |
Palo Alto Investors LP | 2,135,739 | $8,244,000 | 0.41% |
Opus Point Partners Management, LLC | 99,959 | $386,000 | 0.32% |
Granahan Investment Management | 1,527,837 | $5,897,000 | 0.17% |
WALL STREET ASSOCIATES | 367,200 | $1,417,000 | 0.13% |
CAXTON CORP | 21,870 | $84,000 | 0.10% |
SHEPHERD KAPLAN KROCHUK, LLC | 107,392 | $415,000 | 0.07% |
Joel Isaacson & Co., LLC | 70,660 | $273,000 | 0.07% |